CEVR analyzes the value of strategies to improve health and health care.

About Us

Recent Publications

Frontiers in Pharmacology
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
View publication
July 2, 2025
Value in Health
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States
View publication
June 19, 2025
Value in Health
US Drug Pricing Patterns Before Loss of Exclusivity
View publication
April 8, 2025
Health Affairs Scholar
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022
View publication
April 4, 2025
JMCP
Assessing variation in US payer coverage of anti–vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema
View publication
April 3, 2025
Health Affairs Forefront
Bringing Systems Thinking To Drug Value Assessment
View publication
March 11, 2025
Health Affairs Forefront
Medicare Coverage Of Medical Technologies In A New Era
View publication
March 6, 2025

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.